Are you surprised that target therapeutics for metastatic RCC have not improved survival?
Yes
53%
(37 votes)
No
44%
(31 votes)
Haven't thought about it
3%
(2 votes)
Total Votes: 70
See this poll on:
https://poll.fm/8303566/embed